Skip to content

Micra Acute Performance Japan Regional Cohort

Micra Acute Performance Japan Regional Cohort - MAP Japan Regional Cohort

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000036131
Enrollment
300
Registered
2019-03-08
Start date
2019-04-22
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bradycardia

Interventions

None listed

Sponsors

Medtronic Japan Co., Ltd
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements 2. Patient is intended to be treated with an eligible product 3. Patient within enrollment window of therapy received at the time of their initial PSR platform enrollment

Exclusion criteria

Exclusion criteria: 1. Patient who is, or is expected to be inaccessible for follow-up 2. Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results

Design outcomes

Primary

MeasureTime frame
To estimate the acute major complication rate related to the Micra system and/or Micra system implant procedure.

Countries

Japan

Contacts

Public ContactChie Okai

Medtronic Japan Co.,Ltd. Japan Clinical and Medical Affairs

chie.okai@medtronic.com03-6776-0056

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026